The impact of Germany’s human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances
Elizabeth Goodman(Harvard University), Christian Jacob, Monika Hampl(Düsseldorf University Hospital), Wolfgang Greiner(Bielefeld University), Agnes Luzak(MSD (Germany)), Miriam Reuschenbach(MSD (Germany)), Tammo Viering(Carl von Ossietzky Universität Oldenburg)
Cited by 7
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476
A single European currency for EQ-5D health states
|The European Journal of Health Economics|2003|465